Brief serotonin exposure initiates arteriolar inward remodeling processes in vivo that involve transglutaminase activation and actin cytoskeleton reorganization

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 310, Issue 2, 2016, Pages H188-H198

  Foote, Christopher A ^a   Castorena Gonzalez, Jorge A ^a,b   Staiculescu, Marius C ^a   Clifford, Philip S ^c   Hill, Michael A ^a   Meininger, Gerald A ^a   Martinez Lemus, Luis A ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cytoskeleton; Hypertension; Inward remodeling; Nitric oxide; Vasoconstriction; Vasospasm

Indexed keywords

COFILIN; CYSTAMINE; LIM KINASE; N(G) NITROARGININE METHYL ESTER; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SEROTONIN; ACTIN DEPOLYMERIZING FACTOR; ENZYME INHIBITOR; VASOCONSTRICTOR AGENT;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLAR INWARD REMODELLING; ARTERIOLE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; VASCULAR REMODELING; VASOCONSTRICTION; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; IN VITRO STUDY; METABOLISM; PHOSPHORYLATION; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ACTIN CYTOSKELETON; ACTIN DEPOLYMERIZING FACTORS; ANIMALS; ARTERIOLES; CYSTAMINE; ENZYME ACTIVATION; ENZYME INHIBITORS; IN VITRO TECHNIQUES; MALE; MUSCLE, SKELETAL; NG-NITROARGININE METHYL ESTER; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; TRANSGLUTAMINASES; VASOCONSTRICTOR AGENTS;

EID: 84954517417     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00666.2015     Document Type: Article

References (50)

1. Bakker EN, Buus CL, Spaan JA, Perree J, Ganga A, Rolf TM, Sorop O, Bramsen LH, Mulvany MJ, Vanbavel E. Small artery remodeling depends on tissue-type transglutaminase. Circ Res 96: 119-126, 2005
2. Bakker EN, Buus CL, VanBavel E, Mulvany MJ. Activation of resistance arteries with endothelin-1: from vasoconstriction to functional adaptation and remodeling. J Vasc Res 41: 174-182, 2004
3. Bakker EN, Matlung HL, Bonta P, de Vries CJ, van Rooijen N, Vanbavel E. Blood flow-dependent arterial remodelling is facilitated by inflammation but directed by vascular tone. Cardiovasc Res 78: 341-348, 2008
4. Bakker EN, Pistea A, Spaan JA, Rolf T, de Vries CJ, van Rooijen N, Candi E, VanBavel E. Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: possible compensation by macrophage-derived factor XIII. Circ Res 99: 86-92, 2006
5. Bakker EN, van der Meulen ET, van den Berg BM, Everts V, Spaan JA, VanBavel E. Inward remodeling follows chronic vasoconstriction in isolated resistance arteries. J Vasc Res 39: 12-20, 2002
6. Buus NH, Mathiassen ON, Fenger-Gron M, Praestholm MN, Sihm I, Thybo NK, Schroeder AP, Thygesen K, Aalkjaer C, Pedersen OL, Mulvany MJ, Christensen KL. Small artery structure during antihypertensive therapy is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 31: 791-797, 2013
7. Castorena-Gonzalez JA, Staiculescu MC, Foote CA, Polo-Parada L, Martinez-Lemus LA. The obligatory role of the actin cytoskeleton on inward remodeling induced by dithiothreitol activation of endogenous transglutaminase in isolated arterioles. Am J Physiol Heart Circ Physiol 306: H485-H495, 2014
8. Chalouhi N, Tjoumakaris S, Thakkar V, Theofanis T, Hammer C, Hasan D, Starke RM, Wu C, Gonzalez LF, Rosenwasser R, Jabbour P. Endovascular management of cerebral vasospasm following aneurysm rupture: outcomes and predictors in 116 patients. Clin Neurol Neurosurg 118: 26-31, 2014
9. Christensen KL, Mulvany MJ. Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: a literature survey. J Hypertens 19: 1001-1006, 2001
10. Cipolla MJ, Gokina NI, Osol G. Pressure-induced actin polymerization in vascular smooth muscle as a mechanism underlying myogenic behavior. FASEB J 16: 72-76, 2002
11. Dai Y, Dudek NL, Patel TB, Muma NA. Transglutaminase-catalyzed transamidation: a novel mechanism for Rac1 activation by 5-hydroxytryptamine2A receptor stimulation. J Pharmacol Exp Ther 326: 153-162, 2008
12. Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol 11: 906-917, 2012
13. Eftekhari A, Rahman A, Schaebel LH, Chen H, Rasmussen CV, Aalkjaer C, Buus CL, Mulvany MJ. Chronic cystamine treatment inhibits small artery remodelling in rats. J Vasc Res 44: 471-482, 2007
14. Engholm M, Eftekhari A, Chwatko G, Bald E, Mulvany MJ. Effect of cystamine on blood pressure and vascular characteristics in spontaneously hypertensive rats. J Vasc Res 48: 476-484, 2011
15. Feihl F, Liaudet L, Levy BI, Waeber B. Hypertension and microvascular remodelling. Cardiovasc Res 78: 274-285, 2008
16. Guilluy C, Rolli-Derkinderen M, Tharaux PL, Melino G, Pacaud P, Loirand G. Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells. J Biol Chem 282: 2918-2928, 2007
17. Guvenc Tuna B, Lachkar N, de Vos J, Bakker EN, VanBavel E. Cerebral artery remodeling in rodent models of subarachnoid hemorrhage. J Vasc Res 52: 103-115, 2015
18. Hand D, Bungay PJ, Elliott BM, Griffin M. Activation of transglutaminase at calcium levels consistent with a role for this enzyme as a calcium receptor protein. Biosci Rep 5: 1079-1086, 1985
19. Hill MA, Potocnik SJ, Martinez-Lemus LA, Meininger GA. Delayed arteriolar relaxation after prolonged agonist exposure: functional remodeling involving tyrosine phosphorylation. Am J Physiol Heart Circ Physiol 285: H849-H856, 2003
20. Hill MA, Simpson BE, Meininger GA. Altered cremaster muscle hemodynamics due to disruption of the deferential feed vessels. Microvasc Res 39: 349-363, 1990
21. Hungerford JE, Sessa WC, Segal SS. Vasomotor control in arterioles of the mouse cremaster muscle. FASEB J 14: 197-207, 2000
22. Jandu SK, Webb AK, Pak A, Sevinc B, Nyhan D, Belkin AM, Flavahan NA, Berkowitz DE, Santhanam L. Nitric oxide regulates tissue transglutaminase localization and function in the vasculature. Amino acids 44: 261-269, 2013
23. John S, Donnelly M, Uchino K. Catastrophic reversible cerebral vasoconstriction syndrome associated with serotonin syndrome. Headache 53: 1482-1487, 2013
24. Kim HR, Gallant C, Leavis PC, Gunst SJ, Morgan KG. Cytoskeletal remodeling in differentiated vascular smooth muscle is actin isoform dependent and stimulus dependent. Am J Physiol Cell Physiol 295: C768-C778, 2008
25. Koch LG, Alsip NL, Feige BD, Wead WB, Harris PD. In vivo effect of naftidrofuryl on 5-hydroxytryptamine-mediated constriction in rat peripheral microcirculation. Eur J Pharmacol 254: 249-255, 1994
26. Lai TS, Hausladen A, Slaughter TF, Eu JP, Stamler JS, Greenberg CS. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry 40: 4904-4910, 2001
27. Lesort M, Lee M, Tucholski J, Johnson GV. Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders. J Biol Chem 278: 3825-3830, 2003
28. Lukinavicius G, Reymond L, D’Este E, Masharina A, Gottfert F, Ta H, Guther A, Fournier M, Rizzo S, Waldmann H, Blaukopf C, Sommer C, Gerlich DW, Arndt HD, Hell SW, Johnsson K. Fluorogenic probes for live-cell imaging of the cytoskeleton. Nat Methods 11: 731-733, 2014
29. Martinez-Lemus LA. Persistent agonist-induced vasoconstriction is not required for angiotensin II to mediate inward remodeling of isolated arterioles with myogenic tone. J Vasc Res 45: 211-221, 2008
30. Martinez-Lemus LA, Hill MA, Bolz SS, Pohl U, Meininger GA. Acute mechanoadaptation of vascular smooth muscle cells in response to continuous arteriolar vasoconstriction: implications for functional remodeling. FASEB J 18: 708-710, 2004
31. Martinez-Lemus LA, Hill MA, Meininger GA. The plastic nature of the vascular wall: a continuum of remodeling events contributing to control of arteriolar diameter and structure. Physiology (Bethesda) 24: 45-57, 2009
32. Martinez-Lemus LA, Zhao G, Galinanes EL, Boone M. Inward remodeling of resistance arteries requires reactive oxygen species-dependent activation of matrix metalloproteinases. Am J Physiol Heart Circ Physiol 300: H2005-H2015, 2011
33. Mathiassen ON, Buus NH, Larsen ML, Mulvany MJ, Christensen KL. Small artery structure adapts to vasodilatation rather than to blood pressure during antihypertensive treatment. J Hypertens 25: 1027-1034, 2007
34. Mathiassen ON, Buus NH, Sihm I, Thybo NK, Morn B, Schroeder AP, Thygesen K, Aalkjaer C, Lederballe O, Mulvany MJ, Christensen KL. Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 25: 1021-1026, 2007
35. Mawet J, Boukobza M, Franc J, Sarov M, Arnold M, Bousser MG, Ducros A. Reversible cerebral vasoconstriction syndrome and cervical artery dissection in 20 patients. Neurology 81: 821-824, 2013
36. Moreno-Dominguez A, El-Yazbi AF, Zhu HL, Colinas O, Zhong XZ, Walsh EJ, Cole DM, Kargacin GJ, Walsh MP, Cole WC. Cytoskeletal reorganization evoked by Rho-associated kinase- and protein kinase Ccatalyzed phosphorylation of cofilin and heat shock protein 27, respectively, contributes to myogenic constriction of rat cerebral arteries. J Biol Chem 289: 20939-20952, 2014
37. Moriyama K, Iida K, Yahara I. Phosphorylation of Ser-3 of cofilin regulates its essential function on actin. Genes Cells 1: 73-86, 1996
38. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, Heistad DD. Vascular remodeling. Hypertension 28: 505-506, 1996
39. Otite F, Mink S, Tan CO, Puri A, Zamani AA, Mehregan A, Chou S, Orzell S, Purkayastha S, Du R, Sorond FA. Impaired cerebral autoregulation is associated with vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage. Stroke 45: 677-682, 2014
40. Penumatsa K, Abualkhair S, Wei L, Warburton R, Preston I, Hill NS, Watts SW, Fanburg BL, Toksoz D. Tissue transglutaminase promotesserotonin-induced AKT signaling and mitogenesis in pulmonary vascular smooth muscle cells. Cell Signal 26: 2818-2825, 2014
41. Pistea A, Bakker EN, Spaan JA, Hardeman MR, van Rooijen N, VanBavel E. Small artery remodeling and erythrocyte deformability in L-NAME-induced hypertension: role of transglutaminases. J Vasc Res 45: 10-18, 2008
42. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E. Prognostic significance of small-artery structure in hypertension. Circulation 108: 2230-2235, 2003
43. Shaik S, Chhetri SK, Roberts G, Wuppalapati S, Emsley HC. Reversible cerebral vasoconstriction syndrome with involvement of external carotid artery branches. Neurohospitalist 4: 141-143, 2014
44. Singhal AB, Caviness VS, Begleiter AF, Mark EJ, Rordorf G, Koroshetz WJ. Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology 58: 130-133, 2002
45. Staiculescu MC, Galinanes EL, Zhao G, Ulloa U, Jin M, Beig MI, Meininger GA, Martinez-Lemus LA. Prolonged vasoconstriction of resistance arteries involves vascular smooth muscle actin polymerization leading to inward remodelling. Cardiovasc Res 98: 428-436, 2013
46. Velmurugan GV, Sundaresan NR, Gupta MP, White C. Defective Nrf2-dependent redox signalling contributes to microvascular dysfunction in type 2 diabetes. Cardiovasc Res 100: 143-150, 2013
47. Walsh MP, Cole WC. The role of actin filament dynamics in the myogenic response of cerebral resistance arteries. J Cereb Blood Flow Metab 33: 1-12, 2013
48. Watts SW. Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension. Hypertension 39: 825-829, 2002
49. Watts SW, Priestley JR, Thompson JM. Serotonylation of vascular proteins important to contraction. PLoS ONE 4: e5682, 2009
50. Zemskov EA, Mikhailenko I, Hsia RC, Zaritskaya L, Belkin AM. Unconventional secretion of tissue transglutaminase involves phospholipid- dependent delivery into recycling endosomes. PLoS One 6: e19414, 2011